Diabetic Retinopathy

Over time, high blood sugars can cause damage to retinal vessels and vision loss from diabetic retinopathy.

What is Diabetes Mellitus?

Diabetes is commonly known as elevated blood sugar. It occurs in young people who have trouble producing a substance called insulin that regulates blood sugar, as well as in older people who develop resistance to insulin as they age. Young diabetics are often referred to as Type 1, while older diabetics are ofte referred to as Type 2. There are also some diabetics who exhibit characteristics of both Type 1 and Type 2 diabetes. All types of diabetics suffer similar effects of elevated blood sugar.
When diabetes is uncontrolled it damages blood vessels throughout the body. The longer a person is diabetic and the more poorly the blood sugar levels are controlled, the more likely that person is to suffer blood vessel damage. As diabetes worsens, it first affects the smallest blood vessels, called capillaries, throughout the body. Some of the locations in the body where tiny capillaries are the most important include the kidneys, the nerves in the legs, feet, and hands, and in the light-sensing tissue of the eye called the retina.

What is Diabetic Retinopathy?

The earliest sign of small blood vessel damage in the retina is background diabetic retinopathy, also known as non-proliferative diabetic retinopathy. Background diabetic retinopathy occurs as small blood vessel disease becomes visible in the retina, and your eye doctor can see small aneurysms or hemorrhages (also known as "blood spots") in the retinal tissue at this stage. Most diabetics with background diabetic retinopathy do not know that they have this sign of advancing diabetes, since it does not always affect the vision when it is mildly or moderately severe. However, early detection of background diabetic retinopathy is crucial, as it helps the patient's primary care doctor or endocrinologist (diabetic disease specialist) know the status of the diabetic blood vessel damage throughout the body. The diagnosis of background diabetic retinopathy also lets the patient's eye doctor know that the patient is at a higher risk of vision loss than a patient without background diabetic retinopathy. The guidelines of the American Diabetes Association and American Academy of Ophthalmology reflect that all diabetics should have a dilated eye exam regularly in an effort to detect background diabetic retinopathy while it is still in its early stages.

What is a Diabetic Eye Examination?

When a patient comes to the retinal office for a diabetic eye exam, there are sometimes special imaging tests recommended by the doctor in addition to the dilated eye exam. These tests can include specific pictures of the eye with both regular color digital cameras and special laser cameras. Retinal tomography, or an evaluation of the retinal thickness and the retinal layers, is a unique technology often used to assess the structure and health of the diabetic retina. Fluorescein angiography is another specialized imaging test that allows for detailed visualization of the tiny retinal blood vessels as well as leakage from areas that are diseased. Sometimes an ultrasonic picture of the back of the eye is obtained. During your visit, your doctor will decide which of these tests are important for assessment of the retina. Not every test is recommended at every visit.

What can I do to Preserve Vision?

The cornerstone of saving vision in diabetes remains excellent blood sugar control. Over the last 2 generations, there has been ample, repeated evidence that keeping the blood sugar at an appropriate level, controlling blood pressure, and monitoring cholesterol and fats in the blood are the most effective ways to stave off diabetic retinopathy. It is very important that every diabetic has a good relationship with their primary care team and makes every effort to optimize their diabetic health. A healthy diet, regular exercise several times each week, routine at-home blood sugar monitoring as directed by your diabetic doctor, and ongoing compliance with diabetic medications are the most important part of saving vision in diabetes.

What is Background Diabetic Retinopathy?

If diabetes remains poorly controlled, background diabetic retinopathy advances as there is more and more small blood vessel damage. The small blood vessels continue to collapse and result is varying degrees of retinal ischemia, or poor blood flow to the retinal tissue due to the absence of normal blood vessel supply. Essentially, progressing diabetic retinopathy is like placing a tourniquet on the retina a slowly tightening it. There is currently no technology to restore the lost blood vessels. The lack of these blood vessels itself can cause irreversible vision loss and often limits the vision in diabetics.

What is Diabetic Macular Edema?

, There are two treatable processes that occur as there is less and less normal retinal blood flow. The first is called diabetic macular edema, which means swelling in the retina associated with diabetes. This swelling can blur and distort the vision. The swelling occurs because the walls of the small blood vessels are progressively more damaged in diabetes, and there is leakage of blood and fluid into the cells of the retina.

Read more

What is Proliferative Diabetic Retinopathy?

The second treatable process in diabetic retinopathy is the growth of abnormal new blood vessels in the eye. This process is called proliferative retinopathy. The abnormal new blood vessels in the eye probably appear in response to progressive absence of normal blood vessels, and this is an even more ominous process than diabetic macular edema. Often there is both diabetic macular edema and proliferative diabetic retinopathy in the same patient at the same time. The abnormal new blood vessels seen in proliferative retinopathy are fragile and often will bleed into the vitreous jelly filling the back of the eye. This process is called vitreous hemorrhage, and patients will often see hundreds of spots, swirls, or lines when vitreous hemorrhage begins. Sometimes the hemorrhage can be so dense that there is severe blurring of vision. As the abnormal new blood vessels continue to grow, they get denser and thicker. This process can lead to tugging or traction on the retina, and that is termed a diabetic tractional retinal detachment. Diabetic retinal detachment is the most serious and advanced stage of diabetic retinopathy. Abnormal new blood vessel growth in the eye can be treated in its earlier stages with laser therapy. The laser technique is much different than that applied to diabetic macular edema.

Read more

What is a Vitreous Hemorrhage?

Patients with diabetes develop weak blood vessels in the retina that are prone to bleeding. If bleeding occurs into the vitreous cavity, patients will see many tiny floaters and develop moderate to severe vision loss. The blood inside the eye doesn't harm the eye but it does block the vision. Blood inside the eye will sometimes absorb within a few weeks or months. When the blood absorb the vision improves. If the blood doesn't asborb, vitrecotmy surgery can be performed to improve the vision. Because of the risk of surgery, most surgeons wait anywhwere from one month to 6 months depending on the situation to see if the blood will clear without surgery.

Read more

What is a Diabetic Tractional Retinal Detachment?

Patients with proliferative diabetic retinopathy sometimes develop a tractional retinal detachment. This can occur when scar tissue grows on the surface of the retina and then contracts or is pulled forwward in the eye by the vitreous. When this happens, the retina, which is stuck to the diabetic scar tissue, pulls away from the back of the eye and away from its blood supply. The vision declines and the retina suffers. Tractional retinal detachments can usually be prevented if sufficient pan-retinal laser is administered before the scar tissue progresses. Once there is a tractional retinal detachment surgery can be helpful.

Read more

Diabetic Retinopathy NEWS

Below are current articles from a Google News Feed on Diabetic Retinopathy

Deep learning model detects diabetic eye diseases accurately  Medical Xpress

According to the research findings published in Scientific Reports, the deep learning model detects the severity grade of diabetic retinopathy and macular ...

Widefield Swept-Source Optical Coherence Tomography Angiography of Proliferative Diabetic Retinopathy  Healio

Ophthalmic Surgery, Lasers and Imaging Retina | BACKGROUND AND OBJECTIVE:To demonstrate the utility of widefield swept-source optical coherence ...

Anti-VEGFs as a Treatment for Diabetic Retinopathy and PANORAMA Results  MD Magazine

W. Lloyd Clark, MD, of Palmetto Retina Center, discusses clinical implications of the 52-week PANORAMA results, which found treatment with intravitreal ...

Unraveling role of genetics in the pathogenesis of diabetic retinopathy  Modern Retina

Genetic factors play a key role in the onset and progression of diabetic retinopathy. Diabetic retinopathy (DR) is a major retinal microvascular complication of ...

Using AI to Identify Diabetic Retinopathy and Clinically Significant DME  MD Magazine

Artificial intelligence could be the future of detecting certain diseases in the eye, after a study presented at ASRS 2019 found that the EyeArt system was effective ...

Accuracy of Smartphone-Based AI System for Diabetic Retinopathy  MD Magazine

A recent study examining the effectiveness of an offline, automated smartphone-based AI system could be giving physicians a glimpse into the future of eye ...

AI system shows high sensitivity, specificity for detection of diabetic retinopathy  Healio

CHICAGO — The EyeArt artificial intelligence system for diabetic retinopathy screening demonstrated nearly 96% sensitivity for the detection of moderate or ...

VIDEO: Review finds visual improvements in anti-VEGF for diabetic retinopathy  Healio

CHICAGO — At the American Society of Retina Specialists meeting, Rishi P. Singh, MD, of the Cole Eye Institute at the Cleveland Clinic, discusses a ...

Asthma Medication Stops Changes in Diabetic Retinopathy in Type 1 Diabetes  dLife.com

The asthma medication montelukast, also known as Singulair, can inhibit early changes in diabetic retinopathy, the eye disease which develops due to diabetes, ...

Asthma drug can inhibit changes in early stages of diabetic retinopathy  News-Medical.net

In a study published July 26 online in the journal Diabetes, physician-researchers from University Hospitals Rainbow Babies and Children's Hospital and Case ...

VIDEO: Aflibercept 'greatly reduced' rates of vision-threatening complications in diabetic retinopathy  Healio

CHICAGO — At the American Society of Retina Specialists meeting, W. Lloyd Clark, MD, discusses his presentation on the PANORAMA study for the treatment ...

A cross-sectional study of vitreous and serum high mobility group box-1 levels in proliferative diabetic retinopathy  MD Linx

Researchers conducted this cross-sectional study to ascertain vitreous and serum levels of high mobility group box-1 (HMGB-1) in patients with proliferative ...

Hillrom debuts new handheld telehealth eye camera for diabetic retinopathy screening  FierceBiotech

Hillrom has launched an upgraded version of its handheld retinal camera under its Welch Allyn subsidiary, designed to spot the signs of diabetic retinopathy ...

Smartphone-based system accurate picks up diabetic retinopathy  WPVI-TV

A system using a smartphone and artificial intelligence is proving itself in picking up eye problems in diabetics.

Retina risk app tool empowers diabetic patients worldwide  Modern Retina

A new tool (Retina Risk App, Risk Medical Solutions [RMS]) helps patients with diabetes assess their risk for the development of diabetic eye disease.

Lions Club gets information about diabetic retinopathy  Camden News

James Griffin of the Hope Lions Club spoke to the Camden Lions Club Wednesday about the importance of *service* projects in the civic club, and provided ...

Protocol V Sheds Light on Managing Mild Diabetic Macular Edema  Medscape

Until now, data have been relatively scarce on the optimal treatment timing for patients who have diabetic macular edema with good vision.

Lipid-lowering medications are associated with lower risk of retinopathy and ophthalmic interventions among United States patients with diabetes  MD Linx

In this retrospective cohort analysis, researchers assessed the effect of lipid-lowering medications on diabetic retinopathy and diabetic complications requiring ...

Diabetic Retinopathy, irreversible and leads to vision impairment  Sunday Observer

Sri Lanka , like most countries in the West and Asia is now experiencing a diabetes explosion. The International Diabetic Federation of South East Asia ( IDFSEA ...

Real World Patterns of Diagnosis, Progression, and Treatment in Patients with Diabetic Retinopathy Over Five Years  DocWire News

Over five years, patients with an initial diagnosis (ID) of moderate and severe nonproliferative diabetic retinopathy (NPDR) were more likely to develop diabetic ...

Diabetic Retinopathy Market Research Report Outlook 2019 -2023 Resilience and Reinvention in a Changing Marketplace with Size, Share, Growth, Technology, By Diagnosis, Treatment, End-User | MRFR |  Medgadget

Market Highlights The Global Diabetic Retinopathy Market Is Expected To Grow At A CAGR Of 5.2% During The Forecast Period. Diabetic retinopathy is an eye.

AI shows promise in screening diabetic retinopathy: study  The Hindu

Research carried out on patients at city's civic-run dispensaries shows 100% screening reliability.

Diabetic Retinopathy is a Prognostic Factor for Progression of Chronic Kidney Disease in the Patients with Type 2 Diabetes Mellitus  DocWire News

Since both retinopathy and nephropathy are major diabetic microvascular complications, we investigated whether severity of diabetic retinopathy.

Research initiatives offer treatment options for diabetes patients  Optometry Times

The Diabetic Retinopathy Clinical Research Network (DRCR.net) supports the identification, design, and implementation of multicenter clinical research ...

Regeneron's Eylea snags prefilled syringe approval as Novartis rival looms  FiercePharma

Eye med Eylea has been a blockbuster sales force for Regeneron, but Novartis' challenger brolucizumab is on the horizon. Could a new prefilled syringe ...

Global Diabetic Retinopathy Market 2019 – Bayer, F. Hoffmann-La Roche, Novartis, Regeneron Pharmaceuticals  The World Industry News

Market Research always aims at offering their clients an in-depth analysis and the best research material of the various market. This new report on the Global ...

Diabetes Glossary: Definitions of Tests, Treatments, Patients, More  Everyday Health

What do A1C, the keto diet, and metformin have in common? They're popular diabetes terms you may encounter if you or a loved one has been diagnosed with ...

Type 2 diabetes: High blood sugar levels could cause this complication - are you at risk?  Express

Type 2 diabetes is a chronic condition that affects the way a person's body metabolises sugar (glucose). With type 2 diabetes, the body either resists the effects ...

City hospitals amping up resources for diabetic patients  amNY

NYC Health + Hospitals is ramping up efforts to help its patients with diabetes better manage the disease and head off serious medical ailments. Officials said ...

RECOVERY trial looks at retinal nonperfusion area with monthly, quarterly aflibercept  Healio

CHICAGO — Eyes with proliferative diabetic retinopathy treated with monthly aflibercept experienced a stable retinal nonperfusion area after 1 year compared ...

Poly(lactic-co-glycolic acid) nanoparticle-mediated interleukin-12 del | IJN  Dove Medical Press

Poly(lactic-co-glycolic acid) nanoparticle-mediated interleukin-12 delivery for the treatment of diabetic retinopathy.

Artificial intelligence can detect eye disease  The Gazette

IDx, a Coralville-based med technology firm, is giving the world a glimpse into what eye health care might look like in the future. IDx-DR, an autonomous artificial ...

Largest Peer-Reviewed Study on AI in Health Care Shows Real-World Significance of EyeArt AI Eye Screening System from Eyenuk  Business Wire

Eyenuk Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screen.

Hillrom introduces new technology in fight against Diabetic Retinopathy  BSI bureau

New Welch Allyn® RetinaVue® 700 Imager Features Enhanced Security, 60° Degree Field of View and Completely Automated Retinal Image Acquisition in ...

Drugs offer activation combination of Tie2 pathway in DR, DME  Modern Retina

May provide better anatomic improvement, decreased DR severity scores.

‘How do I monitor my eye health?’  The Hindu

Dr R Krishnadas answers readers' questions on optic health and safety.

Dozens of people with visual disabilities ride the waves at Jersey Shore event  NJ.com

Alert Ramirez, 37, center, laughs as she walks toward the ocean for her first surfing lesson during the Visual Experience Foundation's 4th annual Surfing for ...

Diabetic retinopathy: An asthma drug and a few herbs that can heal this condition  TheHealthSite

Diabetic retinopathy, asthma drug and a few herbs, How to treat Diabetic retinopathy, home remedies for this serious condition.

New app could reduce risk of diabetic blindness  SciTech Europa

Retina Risk allows those who suffer from diabetes to assess their own risk of diabetic eye disease. By giving the.

Proliferative Diabetic Retinopathy Market – Key Strategies to Improve Sales in Developed Countries  Gem Newz

The global proliferative diabetic retinopathy market has been thoroughly analyzed in the latest research report developed by Transparency Market Research, ...

Global trends show similar patterns worldwide  Modern Retina

The ASRS Global Trends Survey finds differences in some treatment preferences.

Earlier Detection of Diabetic Retinopathy with Smartphone AI  Michigan Medicine

Pairing a smartphone to capture retinal images with artificial intelligence to interpret them may help overcome barriers to ophthalmic screening for the disease.

Alimera Announces ILUVIEN® Regulatory Approval in Australia for the Treatment of Diabetic Macular Edema  GlobeNewswire

ATLANTA, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a leader in the commercialization and development of ...

Type 2 diabetes: The sign in your eyes you should never ignore - are you at risk?  Express

TYPE 2 diabetes is a common condition that causes the level of sugar in the blood to become too high. A person's eyesight might hold the key to whether they ...

Visual Reality: Diabetic Retinopathy - CE Information  Healio

Education Lab | Visual Reality: Diabetic Retinopathy.

FDA Approves New Injection for Diabetic Retinopathy  dLife.com

Regeneron Pharmaceuticals, Inc. announced yesterday that the U.S. Food and Drug Administration (FDA) has approved EYLEA® (aflibercept) Injection to treat ...

Obesity + diabetic retinopathy: Korean study explores inverse association  Modern Retina

A Korean study identified an inverse association between vision-threatening diabetic retinopathy and body fat in patients with type 2 diabetes. Previous studies ...

Double-Barreled Biologic for Diabetic Retinopathy Emerging  Medscape

Trial results for the first biologic to target both the VEGF and Ang-2 pathways designed for less frequent injections than current options will be presented at the ...

Diabetic Retinopathy Market to Reach USD 13.04 billion By 2026 | Reports And Data  GlobeNewswire

Factors contributing to high CAGR are growing prevalence of diabetes along with rising incidence of blindness. Moreover, increase in purchasing power and the ...

Will Your iPhone's Dark Mode Save Your Eyes? This And Other Ophthalmology & Health Insights  Forbes

With the nearsightedness epidemic, increasing rates of diabetic retinopathy and an aging population in need of cataract surgery, ophthalmologists are in high ...

A Patient’s Guide to Eye Disease  U.S. News & World Report

Learn about common eye diseases, as well as the symptoms, causes and treatment options, at U.S. News and World Report.

FDA Action Alert: Regeneron, Kala and Vanda  BioSpace

Now that July has come and gone, the U.S. Food and Drug Administration is back to work approving drugs. This week marks three PDUFA target action dates, ...

How does diabetic retinopathy influence cataract surgery?  Ophthalmology Times

Study compares preoperative risk factors, co-pathology in patients.

Diabetic Retinopathy Exams in Primary Care  Physician's Weekly

May 13, 2019 | Articles | 0 |. Unfortunately, in most practices, less than 50% of people with diabetes make it to an eye care specialist for a critical, sight-saving ...

Diabetic Retinopathy & Eye Screenings  Endocrinology Advisor

Patients with type 1 or type 2 diabetes are at risk for developing diabetic retinopathy. Eye screening programs are important to preserve vision.

Diabetic Retinopathy Drugs Market SWOT Analysis and Future Growth Prospects from 2019-2025 | Novartis, Bayer Healthcare, Roche  Daily Watch Reports

Global Diabetic Retinopathy Drugs market 2019-2025 in-depth study accumulated to supply latest insights concerning acute options. The report contains ...

Alimera Sciences Announces Multiple Papers “On Demand” at the 2019 American Society of Retina Specialists Annual Meeting  GlobeNewswire

ATLANTA, July 23, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader in the commercialization and development of ...

Ophthalmoscopes Market to Flourish with an Impressive CAGR by 2025  NewsStoner

A handheld device employed to examine the interior structure of eyes is known as ophthalmoscope. Ophthalmoscopes are combined with a source of light and ...

Diabetes Blindness New Treatment  Healthline

The drug Eyela can be used to treat the early stages of diabetic retinopathy, reducing the chances of serious vision loss.

Researchers Suggest Biomarker Screening for Diabetic Retinopathy  AJMC.com Managed Markets Network

Genetics are believed to play a role in who develops diabetic retinopathy, because many patients live for years with diabetes and never develop the ocular ...

Montelukast may inhibit changes in diabetic retinopathy in type 1 diabetes, finds study  Specialty Medical Dialogues

Montelukast may inhibit changes in diabetic retinopathy in type 1 diabetes, finds a new study. In a new study physician-researchers from University Hospitals ...

Diabetic Retinopathy Market Shares, Growth rate, Industry Size, and Future Forecasts to 2026  Finance Express

Industry Overview Of The Diabetic Retinopathy Market. The Diabetic Retinopathy Market Insights and Future Forecast, Report 2019-2026 provides a specific tool ...

BMC study helps detect diabetic blindness easily  Times of India

A study done in the BMC's dispensaries with a smartphone camera has shown that artificial intelligence (AI) can accurately diagnose diabetic retinopat.

Diabetic Retinopathy Drugs Market Outlook & Worldwide Foresight to 2025 key players  ScoopJunction

Market study report Titled Global Diabetic Retinopathy Drugs Market 2019 Industry Research Report is now available at Researchunt. This one of a kind report ...

Diabetic Retinopathy Treatment Market Competition Situation Research Report from 2019-2025 | Regeneron Pharmaceuticals, ThromboGenics, Genentech  Daily Watch Reports

Global Diabetic Retinopathy Treatment market 2019-2025 in-depth study accumulated to supply latest insights concerning acute options. The report contains ...

Global Diabetic Retinopathy Treatment Market poised to expand with robust pace by 2019 -2025 -  Detail Herald

The comprehensive study covers hard to find facts about the Diabetic Retinopathy Treatment market landscape as well as its growth prospects in the years to ...

CBM See the Way appeal tops £1.8m  Inspire Magazine

Overseas disability charity Christian Blind Mission has raised over £1.8 million for their See the Way appeal to help people with sight problems in the world's ...

FDA approves Regeneron's Eylea for diabetic retinopathy  Healio

The FDA has approved Regeneron Pharmaceuticals' aflibercept injection, Eylea, for the treatment of all stages of diabetic retinopathy.The approval was based ...

NYC Health + Hospitals Launches Primary Care-Centered Diabetes Management Program -  HIT Consultant

NYC Health + Hospitals, the largest public health care system in the nation announced the launch of a comprehensive, primary care-centered diabetes ...

Global Diabetic Retinopathy Treatment Market 2019 is Prognosticated to Grab a Massive Chuck of Demand  Wealth News Times

This “Diabetic Retinopathy Treatment Market” report provides a detailed study on the market and how it is impacting the Diabetic Retinopathy Treatment industry.

2019 Diabetic Retinopathy Market Identifying Key Business Opportunities, Size, Trends and Forecast 2025  Rise Media

ReportsnReports added a new report on The Diabetic Retinopathy Market report delivers the clean elaborated structure of the Report comprising each and ...

Diabetic Retinopathy Global Clinical Trials Review, H1, 2019  News Exterior

“Diabetic Retinopathy Global Clinical Trials Review, H1, 2019” provides an overview of Diabetic Retinopathy clinical trials scenario. This report provides top line ...

Disease Pathways for Diabetic Retinopathy Vary Between Patients  Endocrinology Network

Diabetic retinopathy is the leading cause of blindness among working adults in the United States, but disease pathways may vary between patients, new ...

Statins May Prevent Diabetic Retinopathy in People with Diabetes  EndocrineWeb

Individuals with diabetes who were taking a statin for high blood cholesterol have the added benefit of reducing their risk of developing diabetic retinopathy, and ...

EyePACS Surpasses 750,000 Patient Encounters for Diabetic Retinopathy Assessment  PRNewswire

SANTA CRUZ, Calif., June 18, 2019 /PRNewswire/ -- EyePACS LLC, a privately held company and the leading diabetic retinopathy telemedicine provider in the ...

Palatin's (PTN) to Report Q4 Earnings: What's in the Cards?  Yahoo Finance

Palatin Technologies, Inc. PTN will focus on the commercialization of Vyleesi in the fourth quarter of fiscal 2019. Shares of the company have rallied 23.9% year ...

TMR's Recent Publication includes an Extensive Analysis on the Ocular Drug Delivery Technology Market  ScoopJunction

This report on the Global Ocular Drug Delivery Technology market analyzes the current and future scenario of the global market. Rise in private and public ...

Diabetic Retinopathy Clinical Trials Review H1 Market Volume Analysis, Segments, Value Share and Key Trends 2018-2026  Financial Newspaper

Diabetic Retinopathy Clinical Trials Review H1 Market Report by Material, Application, and Geography Global Forecast to 2021 is a professional and in-depth ...

VIDEO: AI-based diabetic retinopathy screening device shows 'exceptional results'  Healio

VANCOUVER, British Columbia — Kaushal Solanki, PhD, founder and CEO of Eyenuk Inc., discusses study results of the EyeArt AI Screening System for ...

Anti-VEGF injections may play increasing role in treatment of diabetic retinopathy  Healio

Ocular Surgery News | Patients with diabetic macular edema and moderately severe to severe nonproliferative diabetic retinopathy, as determined on the ...

Glycemic Threshold for Diabetic Retinopathy Differs By Ethnicity  Diabetes In Control

Future studies should be designed to assess sociodemographic variables and how these influence the risk of diabetic retinopathy and glycemic threshold.

Clinician-AI combination is best in diagnosing diabetic retinopathy  Health Data Management

Assisted by a deep-learning algorithm, physicians were able to more accurately diagnose diabetic retinopathy—a potentially blinding eye disease—than either a ...

British deputy high commissioner reviews diabetic retinopathy prog  Times of India

Visakhapatnam: The British deputy high commissioner, Andrew Fleming toured Vizianagaram district to review the Diabetic Retinopathy programme taken up.

AI Supports Diagnosis of Diabetic Retinopathy  Technology Networks

Technology Networks is an internationally recognised publisher that provides access to the latest scientific news, products, research, videos and posters.

Global Diabetic Retinopathy Treatment Market Insights 2019-2026: Regeneron Pharmaceuticals, ThromboGenics, Genentech  World Industry Reports

Report Diabetic Retinopathy Treatment covers all aspects of the “Diabetic Retinopathy Treatment Market“. It provides basic market terminology and advanced ...

More Diabetic Retinopathy Screening? Primary Care May Be the Answer  MedPage Today

Primary care may be an untapped resource for diabetic retinopathy screening, a new study suggested. In a survey of over 3,200 adults with diabetes, nearly 88% ...

Paintsville woman to participate in fourth JDRF Ride to Cure  The Paintsville Herald

A Paintsville woman has signed up to take part in her fourth Juvenile Diabetes Research Foundation Ride to Cure Diabetes event after several years of ...

App Offers Retinopathy Screening for Patients with Diabetes  Pharmacy Times

Retina Risk is a new app that patients can use to help screen for their risk of retinopathy.

Researchers uncover protective factor in diabetic eye disease  Medical Xpress

Researchers at Joslin Diabetes Center have shown that a protein found in the eye can protect against and potentially treat diabetic eye disease. At high enough ...

Global Diabetic Retinopathy Treatment Market Growth, Key Manufacturers Analysis and Regional Forecast 2018-2025  US Trade Media

Diabetic Retinopathy Treatment Market market research report. This report contains important information to help identify and analyze market needs, size of the ...

Deep learning-enhanced device detects diabetic retinopathy  Medical Xpress

(HealthDay)—A deep learning-enhanced device can accurately detect diabetic retinopathy (DR), according to a study published online Feb. 14 in Diabetes Care ...

FDA Clears AI Device for Diabetic Retinopathy Diagnosis  DARKDaily.com - Laboratory News

FDA clearance of an AI system for diagnosing diabetic retinopathy using retinal images shows medical potential of deep learning and algorithmic analysis.

Using artificial intelligence to automate screening for diabetic retinopathy  Ophthalmology Times

A Deep Learning System (DLS) is an advanced form of artificial intelligence (AI) that can start with a mix of images from different groups and then learn to ...

Eyenuk launches AI diabetic retinopathy screening service  Healio

Eyenuk has launched its EyeScreen Human + AI Diagnostic *Service* for diabetic retinopathy, according to a press release.The artificial intelligence technology ...

Diabetic Retinopathy Market to Hit $12 Billion by 2025: Global Market Insights Inc.  Yahoo Finance

The Asia Pacific diabetic retinopathy market is set to achieve 7.2 percent CAGR from 2019 to 2025, owing to the increasing prevalence of diabetes and ...

BLOG: Laser still has an important role in diabetic eye disease  Healio

Ophthalmology Blogs | Mali | There is no question that the introduction of anti-VEGF agents has dramatically changed the landscape of how surgeons approach ...

Your safety depends on machine learning  Big Think

Your safety depends on machine learning. It's not a cure-all -- unfortunately, there's no way to achieve 100% guaranteed security in this life. Here are some ...

Diet Soda Linked to Increased Risk for Diabetic Retinopathy  Medscape

Drinking diet soda may increase the risk for proliferative diabetic retinopathy — a severe type of diabetic eye disease that can lead to blindness — according to a ...

Diabetic retinopathy: check the epidemic  Deccan Herald

Diabetic Retinopathy is one of the leading causes of vision loss in people with diabetes, especially the working age group.

Jennifer Lim, MD: Training & Testing AI to Detect Diabetic Retinopathy  MD Magazine

After training the EyeArt system on thousands of images of eyes with diabetic retinopathy, investigators tested the AI in a clinical trial.

» Load more

What about Resources?

Dr. Pautler's Blog

This site is not designed to and does not provide medical advice, professional diagnosis, opinion, treatment or services to you or to any other individual. Through this site and linkages to other sites, The information provided in this site, or through linkages to other sites, is not a substitute for medical or professional care, and you should not use the information in place of a visit, call consultation or the advice of your physician or other healthcare provider.

IF YOU BELIEVE YOU HAVE A MEDICAL EMERGENCY, YOU SHOULD IMMEDIATELY CALL 911 OR YOUR PHYSICIAN. If you believe you have any other health problem, or if you have any questions regarding your health or a medical condition, you should promptly consult your physician or other healthcare provider. Never disregard medical or professional advice, or delay seeking it, because of something you read on this site or a linked website. Never rely on information on this website in place of seeking professional medical advice. You should also ask your physician or other healthcare provider to assist you in interpreting any information in this Site or in the linked websites, or in applying the information to your individual case.

Medical information changes constantly. Therefore the information on this Site or on the linked websites should not be considered current, complete or exhaustive, nor should you rely on such information to recommend a course of treatment for you or any other individual. Reliance on any information provided on this Site or any linked websites is solely at your own risk.